Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
SWOG Cancer Research Network
Status
Recruiting
NCT ID
NCT03723928
This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using markers to prompt when scans should be ordered may be as good as the usual approach to monitoring disease.
Intervention
Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring
Condition
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, HER2/Neu Negative, Progesterone Receptor Positive, Prognostic Stage IV Breast Cancer AJCC v8, Elevated CA15-3 or CEA or CA27-29
Investigators
Melissa Accordino, Christopher M. Reynolds, Bryan A. Faller, Howard M. Gross, Pratima Chalasani, Augusto C. Ochoa, Douglas J. Weckstein, Emily G. Robinson, Timothy D. Moore, Rex B. Mowat, Serge Dauphin, Dany El-Sayah, Melissa K. Accordino, Kathleen J. Yost, Richard L. Deming, Jeffrey L. Berenberg, Sima Ehsani, Drew S. Dill, Jay W. Carlson, Sarah S. Mougalian, Shalini Mulaparthi, Brian R. Murphy, Eric Bravin, Paul M. Barr, Ana Maria Lopez, Corrine L. Zarwan, Thomas J. Summers, Ursa A. Brown-Glaberman, Nicholas DiBella, Lara N. Durna, John M. Schallenkamp, Gary C. Doolittle, Mehmood H. Hashmi, Matthew L. Ryan, David M. King, Samer S. Kasbari, Janelle M. Meyer, Demet Gokalp Yasar, Preston D. Steen, Eric Y. Chen, John A. Pablo, Charles W. Drescher, John A. Ellerton, Robert S. Kantor, Michael A. Schwartz, Jade Jones, Ki Y. Chung, Isoken Koko, Luiz O. Pita De Oliveira, Shahzad Siddique, Richard J. Bold, Lisa Bailey, Shelly S. Lo, Salahuddin Siddiqui, Joseph Sokhn, Christos Papageorgiou, Amy D. Tiersten, Nadia N. Ramdin, Jeffrey A. Stevens, Andrew J. Huang, David E. Marinier, Site Public Contact, Sindhu Malapati, Charles H. Shelton, Joseph J. Merchant, Luis J. Santos Reyes, Adam J. Goldrich, Naveed A. Rana, Ana M. Ventura
CT Research Area
Symptom Science

See list of participating sites